Quebec, Ontario add Albrioza to public reimbursement list
Amylyx Pharmaceuticals Canada has entered into product listing agreements with Quebec and Ontario to publicly reimburse Albrioza (sodium…
Articles by Mary Chapman
MTPA joins with ALS/MND patient registry with goal of better care
To better understand amyotrophic lateral sclerosis (ALS) and improve patient care, Mitsubishi Tanabe Pharma America (MTPA) is…
Nonprofit CureALS launches to combat ALS, related disorders
Bill Nuti, the former CEO and chairman of NCR Corporation, is on a mission to eliminate amyotrophic lateral sclerosis…
All MLB teams playing on Lou Gehrig Day June 2
Today marks the third annual Major League Baseball (MLB) Lou Gehrig Day, set aside to honor the legacy of…
This year’s Chicago Walk to Defeat ALS set for Wheaton’s Cantigny Park
On June 3, the Greater Chicago Chapter of the ALS Association will host its 2023 Chicago Walk to…
PatientsLikeMe ALS contribution expands free PRO-ACT database
The data platform PatientsLikeMe (PLM)Â has made its de-identified amyotrophic lateral sclerosis (ALS) patient database available to scientists…
Kevin Daly college bursary program opens in Canada to help ALS families
Applications are open for the first year of the ALS Canada Kevin Daly Bursary, a grant program for post-secondary students…
Improving ALS, FTD research is aim of digital tool grant program
The ALS Association and the Association for Frontotemporal Degeneration (AFTD) have opened a global grant program to accelerate…
US Senate ALS Caucus to advocate for policies, research
The bipartisan Senate ALS Caucus has been reestablished to heighten awareness of the needs of those living with amyotrophic…
Second ALS treatment center of excellence opens in New Jersey
A certified care center of excellence for amyotrophic lateral sclerosis (ALS) has opened in Hackensack Meridian Neuroscience Institute at…